Author

D. Hirschhorn

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Tan· 1 shared C. M. Rice· 1 shared G. Mazo· 1 shared J. Angulo-Lozano· 1 shared J. Choi· 1 shared J. D. Wolchok· 1 shared J. Wang· 1 shared J. Z. Xiang· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Tan

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Innate-adaptive IFN cross-talk reprograms myeloid and T cells for antitumor immunity with a second-generation recombinant MVA

S. Liu, Y. Wang, G. Mazo, S. Baseer Tariq, J. Angulo-Lozano, N. Yang, T. Zhang, Y. Wang, D. Hirschhorn, L. Ji, A. Tan, J. Wang, W. Yan, J. Choi, J. Z. Xiang, , L. Deng

This paper describes a second-generation recombinant MVA vaccine that enhances antitumor immunity by reprogramming myeloid and T cells through innate-adaptive IFN cross-talk.

bioRxiv · Sep 25, 2022 · PreprintImmunology